The Effectiveness and Cost-Effectiveness of Implementing Evidence-Based Depression Treatment within the TB Care Platform in South Africa: A Hybrid Effectiveness-Implementation Trial

在南非结核病护理平台内实施循证抑郁症治疗的有效性和成本效益:一项混合有效性与实施试验

基本信息

项目摘要

PROJECT SUMMARY We propose a Diversity Supplement for Dr. Ernesha Webb Mazinyo to provide her the appropriate setting, training, individualized mentoring and research experience necessary to launch her career as an independently- funded implementation scientist. In order to achieve this goal, Dr. Webb Mazinyo will receive mentoring and research support, didactic coursework in dissemination and implementation science (D&I), hands-on research experience including primary data collection and mixed-methods analysis, and assistance with grant writing and manuscript preparation. Dr. Webb Mazinyo will be mentored by Drs. Annika Sweetland (PI), Andrew Medina- Marino (site-PI, Co-I) and Milton Wainberg (Co-I), to advise her as she pursues D&I research focused on integrating TB, depression and hazardous drinking (HD) treatment within primary care. Drs. Sweetland, Medina- Marino, and Wainberg have relevant methodological expertise in D&I science and mixed-methods research; topical expertise on the intersection of TB, depression and HD; and a successful track-record mentoring early investigators. This application builds upon the parent-study by expanding the scientific scope to include HD among TB patients with and without depression. Dr. Webb Mazinyo will participate in all research activities related to the parent study, including the preparation and submission of scientific papers/proposals, along with didactic and career development activities. Dr. Webb Mazinyo’s hands-on research will include two research aims: AIM 1: To leverage parent study data to estimate the prevalence and social correlates of HD among TB patients with and without depression. AIM 2: To investigate contextual factors and potential barriers/facilitators to integrating treatment for depression and HD within the TB care platform. Taken together, the research activities proposed for this Diversity Supplement will develop Dr. Webb Mazinyo’s D&I research skills and will provide the structure and support needed for her to become a highly successful independent researcher able to address integration of treatment for HD for patients with TB in South Africa and other low-resource settings. Our main objective is to support Dr. Webb Mazinyo to apply for and obtain a K01 award to support her goal of becoming a researcher of the highest caliber in the field of D&I.
项目总结 我们建议为Erensha Webb Mazinyo博士提供多样性补充,为她提供适当的环境, 培训、个性化指导和研究经验是她独立开始职业生涯所必需的- 资助实施科学家。为了实现这一目标,韦布·马齐约博士将接受指导和 研究支持,传播和实施科学(D&I)的教学课程,实践研究 经验,包括主要数据收集和混合方法分析,并协助编写赠款和 手稿准备工作。Webb Mazinyo博士将由Annika Sweetland(PI)博士、Andrew Medina博士指导- Marino(Site-PI,Co-I)和Milton Wainberg(Co-I),在她从事专注于以下方面的D&I研究时为她提供建议 将结核病、抑郁症和危险饮酒(HD)治疗纳入初级保健。斯威特兰博士,麦地那- Marino和Wainberg在D&I科学和混合方法研究方面拥有相关的方法论专业知识; 关于结核病、抑郁症和HD交集的专题专业知识;以及早期成功的跟踪指导 调查人员。这一应用程序建立在家长研究的基础上,将科学范围扩展到包括HD 在患有和不患有抑郁症的结核病患者中。韦伯·马津约博士将参加所有研究活动 与母研究有关,包括编写和提交科学论文/提案,以及 教学和职业发展活动。Webb Mazinyo博士的实践研究将包括两项研究 目标: 目标1:利用父母研究数据来评估结核病中HD的患病率和社会相关性 患有和不患有抑郁症的患者。 目标2:调查整合治疗的环境因素和潜在障碍/促进者 结核病护理平台内的抑郁和HD。 综上所述,为本多样性补充材料提出的研究活动将发展Webb Mazinyo博士的 D&I研究技能,并将提供必要的结构和支持,使她成为一个非常成功的 独立研究人员能够解决南非和南非结核病患者HD治疗的整合问题 其他资源不足的设置。我们的主要目标是支持Webb Mazinyo博士申请并获得K01 奖项支持她成为D&I领域最高水平的研究员的目标。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Annika Claire Sweetland其他文献

Annika Claire Sweetland的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Annika Claire Sweetland', 18)}}的其他基金

The Effectiveness and Cost-Effectiveness of Implementing Evidence-Based Depression Treatment within the TB Care Platform in South Africa: A Hybrid Effectiveness-Implementation Trial
在南非结核病护理平台内实施循证抑郁症治疗的有效性和成本效益:一项混合有效性与实施试验
  • 批准号:
    10366733
  • 财政年份:
    2021
  • 资助金额:
    $ 7.19万
  • 项目类别:
The Effectiveness and Cost-Effectiveness of Implementing Evidence-Based Depression Treatment within the TB Care Platform in South Africa: A Hybrid Effectiveness-Implementation Trial
在南非结核病护理平台内实施循证抑郁症治疗的有效性和成本效益:一项混合有效性与实施试验
  • 批准号:
    10494127
  • 财政年份:
    2021
  • 资助金额:
    $ 7.19万
  • 项目类别:
Integrating evidence-based MDD treatment in primary care: TB in Brazil as a model
将循证 MDD 治疗纳入初级保健:以巴西结核病为典范
  • 批准号:
    9268083
  • 财政年份:
    2016
  • 资助金额:
    $ 7.19万
  • 项目类别:

相似海外基金

Functional evaluation of bioabsorbable small-caliber vascular graft in a diabetic rat model to achieve a practical use
生物可吸收小口径血管移植物在糖尿病大鼠模型中的功能评价以实现实用化
  • 批准号:
    21K08812
  • 财政年份:
    2021
  • 资助金额:
    $ 7.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CALIBER: Conductive Additives to reduce Lithium Ion Battery Electrode Resistance
CALIBER:降低锂离子电池电极电阻的导电添加剂
  • 批准号:
    10004505
  • 财政年份:
    2021
  • 资助金额:
    $ 7.19万
  • 项目类别:
    BEIS-Funded Programmes
Enhanced degradability of bioabsorbable small-caliber artificial vessels to promote autologous vascular regeneration
增强生物可吸收小口径人工血管的降解性促进自体血管再生
  • 批准号:
    21K20938
  • 财政年份:
    2021
  • 资助金额:
    $ 7.19万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Engineering a biomimetic small caliber vascular prosthesis: fabrication of an anti-thrombogenic endothelium from the stromal vascular fraction of adipose tissue
设计仿生小口径血管假体:从脂肪组织的基质血管部分制造抗血栓内皮
  • 批准号:
    518445-2018
  • 财政年份:
    2020
  • 资助金额:
    $ 7.19万
  • 项目类别:
    Postgraduate Scholarships - Doctoral
Elucidation of the mechanism of small caliber axons' myelination in the central nervous system and its application
中枢神经系统小口径轴突髓鞘化机制的阐明及其应用
  • 批准号:
    20K07756
  • 财政年份:
    2020
  • 资助金额:
    $ 7.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Morphological and Biochemical Profiling of the Degeneration of Small Caliber Axons Using a Murine Model for Myelin-related Diseases
使用髓磷脂相关疾病的小鼠模型对小口径轴突变性进行形态学和生化分析
  • 批准号:
    20KK0188
  • 财政年份:
    2020
  • 资助金额:
    $ 7.19万
  • 项目类别:
    Fund for the Promotion of Joint International Research (Fostering Joint International Research (B))
In vitro endothelialization of small caliber vascular prostheses made of bacterial nanocellulose depending on coating with albumin, fibronectin or heparin
由细菌纳米纤维素制成的小口径血管假体的体外内皮化取决于白蛋白、纤连蛋白或肝素的涂层
  • 批准号:
    421965288
  • 财政年份:
    2019
  • 资助金额:
    $ 7.19万
  • 项目类别:
    Research Grants
Engineering a biomimetic small caliber vascular prosthesis: fabrication of an anti-thrombogenic endothelium from the stromal vascular fraction of adipose tissue
设计仿生小口径血管假体:从脂肪组织的基质血管部分制造抗血栓内皮
  • 批准号:
    518445-2018
  • 财政年份:
    2019
  • 资助金额:
    $ 7.19万
  • 项目类别:
    Postgraduate Scholarships - Doctoral
Anti-atherosclerotic action of platelet-derived endothelial cell growth factor to improve patency of small-caliber artificial blood vessels
血小板源性内皮细胞生长因子的抗动脉粥样硬化作用可改善小口径人造血管的通畅性
  • 批准号:
    18K08753
  • 财政年份:
    2018
  • 资助金额:
    $ 7.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Engineering a biomimetic small caliber vascular prosthesis: fabrication of an anti-thrombogenic endothelium from the stromal vascular fraction of adipose tissue
设计仿生小口径血管假体:从脂肪组织的基质血管部分制造抗血栓内皮
  • 批准号:
    518445-2018
  • 财政年份:
    2018
  • 资助金额:
    $ 7.19万
  • 项目类别:
    Postgraduate Scholarships - Doctoral
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了